Sameh Ibrahim, MD
Anesthesiology · Fort Lauderdale, FLNPI 1114020047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Merck at 25.6% of the total.
Across 47 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$267
- Cumberland Pharmaceuticals, Inc.$137
- Medtronic$111
- Pacira Pharmaceuticals Incorporated$74
- Mindray DS USA, Inc.$73
- Edwards Lifesciences$67
- plus $314 from 10 others
What the payments were for
- Food & beverage$1,044100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $267 |
| Cumberland Pharmaceuticals, Inc. | 7 | $137 |
| Medtronic | 4 | $111 |
| Pacira Pharmaceuticals Incorporated | 3 | $74 |
| Mindray DS USA, Inc. | 2 | $73 |
| Edwards Lifesciences | 2 | $67 |
| Mallinckrodt Enterprises LLC | 2 | $53 |
| CSL Behring | 2 | $52 |
| Heron Therapeutics, Inc. | 2 | $48 |
| Covidien LP | 1 | $32 |
| Masimo Corporation | 2 | $32 |
| BD | 1 | $31 |
| Mercury Enterprises, Inc. | 1 | $23 |
| Ambu Inc. | 1 | $15 |
| Eagle Pharmaceuticals, Inc. | 1 | $15 |
| Fujifilm Sonosite, Inc. | 1 | $13 |
How this compares
$1,044 in reported general payments places this provider in the 85th percentile of 2,767 anesthesiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 12 | $8,121 |
| Clonidine | 12 | $751 |
| Ondansetron OdtOndansetron | 12 | $182 |
| Carvedilol | 12 | $20 |
| Amlodipine Besylate | 12 | $2 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Fort Lauderdale
- Robert LondonOrlando$402K
- Todd HorowitzDelray Beach$267K
- Darren WredeLargo$211K
- Ralf GebhardMiami$166K
- Adam BlombergHollywood$120K
- Andre BoezaartGainesville$119K
- Samantha NiekampMiami$82K
- Jackson WagonerGainesville$70K
- Sorin BrullJacksonville$66K
- Roman DudarykMiami$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.